Prognostic Factors and Prognostic Index for Chemonaïve and Gemcitabine-Refractory Patients with Advanced Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|73|1-2|41-51

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.1-2, 2008-03, pp. : 41-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

A Prognostic Model to Predict Clinical Outcomes with First-Line Gemcitabine-Based Chemotherapy in Advanced Pancreatic Cancer

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 175-180

Karger

Access to resources Recommend Favorite

Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer

By  

Oncology, Vol. 83, Iss. 2, 2012-06 ,pp. : 57-66

Karger

Access to resources Recommend Favorite

Updated long‐term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4196-4204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 293-300

Karger

Access to resources Recommend Favorite